Posts Tagged ‘sterile compounding’
North Carolina Pharmacy Law Update: Properly Identifying the Compounding Risk Levels and Notifying the Board
Pharmacies that hold a permit in North Carolina and engage in any type of compounding are required to notify the North Carolina Board of Pharmacy (Board). Pharmacies must report (both on their initial permit application and as part of each annual renewal) the following: Whether they compound; A good-faith estimate of the percentage of the…
Read MoreA Texas Compounder, the FDA and the Texas Board of Pharmacy: State or Federal Oversight?
Last month the Food and Drug Administration (FDA) alerted health care professionals and patients not to use drug products intended to be sterile that are produced and distributed by IV Specialty of Austin, Texas, due to lack of sterility assurance. The FDA found numerous safety issues during its February 2016 which prompted them to recommend…
Read More